 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Foundations of Tumor Immunology

Introduction to Tumor Immunology

Immune Recognition and Antitumor Responses

Cancer Immunoediting

The Three Phases of Cancer Immunoediting

Elimination: Immune Surveillance Against Emerging Tumors

Equilibrium and Escape: Tumor Adaptation Under Immune Pressure

MHC Class I Downregulation and Antigen Presentation Defects

MHC Class I and Tumor Antigen Presentation

Mechanisms and Consequences of MHC Class I Downregulation

Antigen Processing and Presentation Defects

Immune Checkpoint Signaling and Tumor Immune Suppression

Principles of Immune Checkpoint Regulation

PD-1 and PD-L1 Signaling in the Tumor Microenvironment

CTLA-4 Signaling and T-Cell Priming

Integrating Mechanisms of Tumor Immune Evasion

Quiz

Quiz Question 1: Cancer Immunoediting

Quiz Question 2: MHC Class I Downregulation

Quiz Question 3: Antigen Presentation Defects

Quiz Question 4: PD-1/PD-L1 Signaling

Quiz Question 5: CTLA-4 Signaling

Survey and Feedback

Course Feedback Survey

Unlock the complex and dynamic relationship between cancer and the immune system with our comprehensive course, 'Foundations of Tumor Immunology and Immune Evasion Mechanisms. ' As the field of oncology rapidly evolves, understanding how tumors interact with, and ultimately evade, immune surveillance is critical for advancing cancer research and developing life-saving immunotherapies.

Unlock the complex and dynamic relationship between cancer and the immune system with our comprehensive course, 'Foundations of Tumor Immunology and Immune Evasion Mechanisms.' As the field of oncology rapidly evolves, understanding how tumors interact with, and ultimately evade, immune surveillance is critical for advancing cancer research and developing life-saving immunotherapies. This course offers an in-depth exploration of tumor immunology, starting from the foundational concepts of immune recognition and the specific roles of innate and adaptive immune cells, including dendritic cells, natural killer cells, and T cells.

Journey through the three critical phases of cancer immunoediting—elimination, equilibrium, and escape—to discover how the immune system both protects against and inadvertently shapes tumor development. You will delve into the molecular mechanisms of immune evasion, specifically focusing on MHC Class I downregulation and antigen presentation defects that allow cancer cells to hide in plain sight. Furthermore, the course demystifies the complex world of immune checkpoint signaling, providing detailed insights into PD-1/PD-L1 and CTLA-4 pathways. By integrating these concepts, you will learn how tumors suppress immune responses and understand the rationale behind groundbreaking checkpoint blockade therapies. Whether you are a medical student, a biomedical researcher, or a healthcare professional, this course will equip you with the essential knowledge to navigate the forefront of cancer immunotherapy.

Foundations of Tumor Immunology and Immune Evasion Mechanisms

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>The study of tumor immunology provides critical insights into the complex and dynamic interactions between cancer cells and the host immune system. This course, "Foundations of Tumor Immunology and Immune Evasion Mechanisms," explores the fundamental principles governing how the immune system recognizes and responds to malignancies. Learners will examine the roles of key immune cells, such as dendritic cells, natural killer cells, and various T-cell subsets, in detecting abnormal tumor antigens and orchestrating an initial antitumor response. Furthermore, the curriculum delves into the paradigm of cancer immunoediting, detailing the sequential phases of elimination, equilibrium, and escape. Through this framework, the dual role of the immune system—acting both as a protective mechanism against emerging tumors and as a selective pressure that drives tumor adaptation—is thoroughly analyzed.</p>

<p>Building upon these foundational concepts, the course systematically investigates the sophisticated strategies employed by tumor cells to evade immune surveillance. A significant focus is placed on the mechanisms and consequences of Major Histocompatibility Complex class I (MHC-I) downregulation, alongside specific defects in the antigen processing and presentation pathways. Additionally, the curriculum provides an in-depth examination of immune checkpoint regulation, specifically highlighting the PD-1/PD-L1 and CTLA-4 signaling pathways within the tumor microenvironment. By integrating these diverse mechanisms of immune evasion, learners will develop a comprehensive understanding of how tumors suppress T-cell function and persist despite active immune responses. Ultimately, this knowledge establishes the scientific rationale for contemporary immunotherapies, equipping learners to evaluate how targeted combination approaches can effectively counteract tumor-induced immune suppression.</p>
        </div>
    </div>
</div>
